InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
16
T+90 hit rate
71%
T+90 mean return
+6.8%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Sanna Bastiano, Vice-Président Exécutif, Thérapies Cellulaires et Génétiques. Officer active across 3 companies, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 36 disclosures have been recorded. Split: 0 buy · 16 sells. Total volume traded: €3.3m. Activity tracked since 30 April 2021. The latest transaction was disclosed on 1 June 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations36 total
5,900 shares0Common StockSEC:0001209191-23-033960:0
▼
422 shares@ US$350.031.5% of flowCommon StockSEC:0001209191-23-028243:0
▼
1,411 shares@ US$350.325.2% of flowCommon StockSEC:0001209191-23-027374:0
▼
874 shares@ US$325.703.0% of flowCommon StockSEC:0001209191-23-024312:0
211 shares@ US$314.220.7% of flowCommon StockSEC:0001209191-23-023588:0
●
1,466 shares@ US$313.744.8% of flowCommon StockSEC:0001209191-23-022695:0
▼
2,482 shares@ US$300.548.1% of flowCommon StockSEC:0001209191-23-020043:0
3,970 shares@ US$289.1212.4% of flowCommon StockSEC:0001209191-23-013757:0
3,750 shares@ US$292.8511.8% of flowCommon StockSEC:0001209191-23-011701:0
▼
1,902 shares@ US$300.296.1% of flowCommon StockSEC:0001209191-23-010055:0
●
902 shares@ US$294.332.8% of flowCommon StockSEC:0001209191-23-009232:0
9,092 shares0Common StockSEC:0001209191-23-006980:0
106 shares@ US$325.000.4% of flowCommon StockSEC:0001209191-23-006215:0
●
768 shares@ US$312.842.8% of flowCommon StockSEC:0000899243-22-034883:0
▼
1,503 shares@ US$300.025.2% of flowCommon StockSEC:0000899243-22-033880:0
●
766 shares@ US$276.622.4% of flowCommon StockSEC:0000899243-22-027571:0
7 shares@ US$250.560.0000% mcap0.1% of flowCommon StockSEC:0000899243-22-018605:0
36 shares@ US$275.090.0000% mcap0.3% of flowCommon StockSEC:0000899243-22-017086:0
20 shares@ US$255.470.0000% mcap0.2% of flowCommon StockSEC:0000899243-22-016641:0
●
766 shares@ US$276.170.0002% mcap7.1% of flowCommon StockSEC:0000899243-22-016316:0
204 shares@ US$275.710.0000% mcap1.8% of flowCommon StockSEC:0000899243-22-014360:0
305 shares@ US$267.100.0001% mcap2.6% of flowCommon StockSEC:0000899243-22-014120:0
●
1,344 shares@ US$263.090.0003% mcap11.2% of flowCommon StockSEC:0000899243-22-013705:0
▼
2,122 shares@ US$250.060.0004% mcap16.9% of flowCommon StockSEC:0000899243-22-011701:0
●
3,439 shares@ US$232.510.0006% mcap24.6% of flowCommon StockSEC:0000899243-22-007215:0
25 of 36 declarations
About Sanna Bastiano
Sanna Bastiano is associated with VERTEX PHARMACEUTICALS INC / MA.
